ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag amazon immunology culture microbiology

The Search for Persisters
Amanda B. Keener | Aug 11, 2015 | 4 min read
Lyme disease–causing bacteria can outmaneuver antibiotics in vitro and manipulate the mouse immune system.
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Suited to a T
Kelly Rae Chi | May 1, 2013 | 8 min read
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Making Things Grow: Insect Cells, Stem Cells, and Primary Cell Lines All Pose Challenges for Cell Culturists
Laura Defrancesco | Jun 21, 1998 | 5 min read
Date: June 22, 1998 Insect Cell Culture Media, Suppliers of Primary Cell Culture Media Advantages for Protein Expression Studies Since the mid-1950s cultures of insects--cockroaches, fruit flies, and leafhoppers, to name a few--have been the object of quiet study by physiologists and cell biologists. But along came genetic engineering and suddenly insect cultures have been put in the spotlight since they provide advantages over both bacterial and mammalian systems for recombinant protein prod
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Contributors
Amanda B. Keener | Jul 1, 2015 | 3 min read
Meet some of the people featured in the July 2015 issue of The Scientist.
Drawn to Controversy
Megan Scudellari | Jan 1, 2014 | 8 min read
By digging through dusty storerooms and reading dead people’s mail, science historian and philosopher Michael Dietrich keeps biologists attuned to the past and mindful of the present.
Macro, Mini, Micro
Carina Storrs | Jan 1, 2013 | 7 min read
Clever microfluidic platforms take the study of protein-protein interactions to a new level.
Human Clinical Trials Begin For Cervical Cancer Vaccines
Steve Bunk | Oct 26, 1997 | 6 min read
Efforts are under way to develop a vaccine against one of the world's deadliest illnesses, cervical cancer. Along with a number of university research laboratories, at least a half-dozen biotechnology and pharmaceutical companies are beginning clinical trials or are in preclinical development of such drugs. Efficacy in humans remains to be firmly established, but if the vaccines progress to later-phase trials, challenging jobs for immunologists, microbiologists, and biochemists will multiply. "
AIDS 20 Years Later...
Myrna Watanabe | Jun 10, 2001 | 10+ min read
On June 5, 1981, a one-and-a-half page paper in Morbidity and Mortality Weekly Report (MMWR) noted cases of Pneumocystis carinii pneumonia in five gay men in Los Angeles. The men also suffered from cytomegalovirus (CMV) infections and candidal infections of the mucosa,1 and they used recreational inhalant drugs. The editorial note pointed out: "Pneumocystis pneumonia in the United States is almost exclusively limited to severely immunosuppressed patients." "I was sitting in my office in Buildi

Run a Search

ADVERTISEMENT